Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase

Eur J Clin Invest. 1989 Oct;19(5):415-8. doi: 10.1111/j.1365-2362.1989.tb00252.x.

Abstract

Porphobilinogen deaminase, the third enzyme of the haem biosynthetic pathway, is encoded by two distinct mRNA species expressed in a tissue-specific manner from a single gene. These two mRNAs are transcribed from two promoters and only differ in their first exon. An inherited deficiency or porphobilinogen deaminase in man is responsible for the autosomal dominant disease acute intermittent porphyria. Different classes of mutations have been described at the protein level suggesting that this is a heterogeneous disease. In the present report, we describe the molecular abnormality responsible for a variant form of acute intermittent porphyria where the enzyme defect is restricted to non-erythroid cells. Upon cloning and sequencing the mutant allele of a patient from a large Finnish kindred, a single-base substitution within the 5'-splice donor sequence of intron 1 was found at the last position of exon 1 (CG----CT). The identification of this mutation allowed us to detect asymptomatic gene carriers among family members using in vitro amplification of DNA and hybridization of the target sequence to allele-specific oligonucleotides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ammonia-Lyases / genetics*
  • Base Sequence
  • Cloning, Molecular
  • DNA / genetics
  • Erythrocytes / enzymology*
  • Female
  • Finland
  • Genetic Carrier Screening
  • Humans
  • Hydroxymethylbilane Synthase / blood
  • Hydroxymethylbilane Synthase / genetics*
  • Male
  • Molecular Sequence Data
  • Mutation
  • Porphyrias / enzymology
  • Porphyrias / genetics*

Substances

  • DNA
  • Hydroxymethylbilane Synthase
  • Ammonia-Lyases